Clinical Trial Update: Efficacy and Safety of Individualized P2Y12 Receptor Antagonists Treatment Based on Agregometry Versus Fixed Dose Regimen in Patients After Acute Myocardial Infarction [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating individualized P2Y12 receptor antagonist therapy based on aggregometry versus fixed dosing after acute myocardial infarction, assessing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• St-elevation Myocardial Infarction

Drugs mentioned

• P2Y12 receptor antagonists (individualized therapy)

Snippet

Sponsor: University of Zagreb | Conditions: Acute Coronary Syndrome, STEMI | Phase 4 | Status: COMPLETED